De A. Pereira
Hospital De Doenças Tropicais Dr. Anuar Auad
Goiania, GO, Brazil
Goiania, GO, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis.
Journal: Frontiers in cellular and infection microbiology
Published: April 26, 2021
Case Report: Atypical Cutaneous Leishmaniasis in a Patient with Mixed Leishmania guyanensis and Leishmania amazonensis Infection.
Journal: The American journal of tropical medicine and hygiene
Published: September 12, 2018
A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis.
Journal: Revista da Sociedade Brasileira de Medicina Tropical
Published: August 14, 2018
Susceptibility to Miltefosine in Brazilian Clinical Isolates of Leishmania (Viannia) braziliensis.
Journal: The American journal of tropical medicine and hygiene
Published: January 11, 2017
Identification and Biological Characterization of Leishmania (Viannia) guyanensis Isolated from a Patient with Tegumentary Leishmaniasis in Goiás, a Nonendemic Area for This Species in Brazil.
Journal: BioMed research international
Published: June 05, 2015
In vitro metacyclogenesis of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis clinical field isolates, as evaluated by morphology, complement resistance, and infectivity to human macrophages.
Journal: BioMed research international
Published: November 07, 2014
Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.
Journal: BMC infectious diseases
Published: September 19, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026